Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.49B |
| 2 |
NVIDIA
NVDA
|
+$2.19B |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.94B |
| 4 |
TSMC
TSM
|
+$728M |
| 5 |
UnitedHealth
UNH
|
+$705M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$775M |
| 2 |
AbbVie
ABBV
|
+$540M |
| 3 |
Delta Air Lines
DAL
|
+$434M |
| 4 |
Eli Lilly
LLY
|
+$433M |
| 5 |
DexCom
DXCM
|
+$433M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.89% |
| 2 | Healthcare | 2.92% |
| 3 | Financials | 2.71% |
| 4 | Consumer Discretionary | 2.52% |
| 5 | Industrials | 2.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
10651
Polen Capital International Growth ETF
PCIG
$29.6M
| $235K | ﹤0.01% |
25,750
+13,677
| +113% | +$127K |
|
10652
PUT
ProShares Ultra Energy
DIG
$85.6M
| $235K | ﹤0.01% |
+6,500
| New | +$233K |
|
10653
Flexible Solutions
FSI
$64.2M
| $234K | ﹤0.01% |
+34,825
| New | +$275K |
|
|
CRDU
10654
Tradr 2X Long CRDO Daily ETF
CRDU
$118M
| $234K | ﹤0.01% |
+20,748
| New | +$297K |
|
10655
PUT
Sabre
SABR
$900M
| $234K | ﹤0.01% |
172,200
-1,528,000
| -90% | -$2.63M |
|
10656
CALL
Dimensional US Core Equity Market ETF
DFAU
$12.9B
| $234K | ﹤0.01% |
+5,000
| New | +$232K |
|
10657
PUT
Paymentus
PAY
$5.27B
| $234K | ﹤0.01% |
7,400
-10,800
| -59% | -$352K |
|
10658
CALL
Progyny
PGNY
$2.02B
| $234K | ﹤0.01% |
9,100
-9,800
| -52% | -$225K |
|
10659
Karyopharm Therapeutics
KPTI
$45.8M
| $233K | ﹤0.01% |
+31,709
| New | +$194K |
|
10660
WisdomTree Yield Enhanced US Aggregate Bond Fund
AGGY
$923M
| $233K | ﹤0.01% |
5,291
-24,992
| -83% | -$1.11M |
|
|
FPI
10661
CALL
Farmland Partners
FPI
$433M
| $233K | ﹤0.01% |
24,000
+12,800
| +114% | +$128K |
|
10662
PUT
Revolve Group
RVLV
$1.68B
| $232K | ﹤0.01% |
7,700
-174,100
| -96% | -$4.21M |
|
|
SY
10663
PUT
So-Young International
SY
$225M
| $232K | ﹤0.01% |
90,800
+51,200
| +129% | +$166K |
|
10664
CALL
The RMR Group
RMR
$346M
| $232K | ﹤0.01% |
15,600
-5,500
| -26% | -$83.7K |
|
10665
PUT
Alight
ALIT
$372M
| $232K | ﹤0.01% |
5,945
-3,335
| -36% | -$166K |
|
10666
PUT
AdvanSix
ASIX
$460M
| $232K | ﹤0.01% |
13,400
-14,600
| -52% | -$255K |
|
|
AQEC
10667
AQE Core ETF
AQEC
$622M
| $232K | ﹤0.01% |
+8,960
| New | +$230K |
|
|
CANG
10668
Cango Inc
CANG
$84.1M
| $232K | ﹤0.01% |
+15,443
| New | +$423K |
|
10669
PUT
Veracyte
VCYT
$3.32B
| $232K | ﹤0.01% |
+5,500
| New | +$222K |
|
10670
CALL
Unifirst Corp
UNF
$5.19B
| $231K | ﹤0.01% |
+1,200
| New | +$203K |
|
10671
PUT
Itaú Unibanco
ITUB
$81.6B
| $231K | ﹤0.01% |
32,320
+6,827
| +27% | +$48.6K |
|
10672
CALL
Teradata
TDC
$2.57B
| $231K | ﹤0.01% |
7,600
-54,200
| -88% | -$1.42M |
|
|
SNOY
10673
YieldMax SNOW Option Income Strategy ETF
SNOY
$68.9M
| $231K | ﹤0.01% |
+18,930
| New | +$271K |
|
|
KW
10674
PUT
DELISTED
Kennedy-Wilson Holdings
KW
| $231K | ﹤0.01% |
23,900
-2,100
| -8% | -$18.8K |
|
|
TOPT
10675
PUT
iShares Top 20 U.S. Stocks ETF
TOPT
$679M
| $231K | ﹤0.01% |
7,400
-14,200
| -66% | -$440K |
|
Similar funds
Ken Griffin's Q4 2025 Portfolio in Review
As of Q4 2025, Ken Griffin held 14,701 positions worth $666B, up 1.3% from $657B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Ken Griffin's Q4 2025 filing shows 2,078 new, 5,000 increased, 5,362 reduced and 2,191 closed positions. Its largest new stake was Medline Inc: 6,006,339 shares worth $252M. The largest sale was Meta Platforms (Facebook), an estimated $775M.
By sector, the portfolio is most concentrated in Technology at 4.9% of assets, up from 3.8% a quarter earlier, followed by Healthcare and Financials.
- Ken Griffin's largest Q4 2025 buy was Medline Inc: 6,006,339 shares worth $252M.
- Ken Griffin added most to Amazon in Q4 2025, an estimated $2.49B increase.
- Ken Griffin's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $775M.
- Ken Griffin fully exited WEX in Q4 2025, selling an estimated $131M.
- Ken Griffin's ten largest holdings make up 23% of its $666B portfolio in Q4 2025.
- Ken Griffin opened 2,078 new positions and closed 2,191 in Q4 2025.
- Ken Griffin's portfolio value rose 1.3% quarter-over-quarter to $666B.
Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.